Global Non-opioid Pain Treatment Markets 2018-2022: Medical Cannabis, Capsaicin-Derived, Menthol, Omega 3 fatty Acid & Botulinum Toxins

Dublin, April 12, 2018 -- The "Non-opioid Pain Treatment: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering.

This report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study addresses acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and
competitive analyses.

The report identifies five general product segments for non-opioid treatment of pain:

• Medical cannabis treatments.
• Capsaicin-derived treatments.
• Menthol-containing treatments.
• Omega 3 fatty acid-containing treatments.
• Botulinum toxins.

Within the segment several sub-segments are discussed as they pertain to each product segment; diseases or disorders are the basis for these sub-segments, including:

• Arthritis.
• Cancer; brain, breast, colorectal, leukemia/lymphoma, melanoma, prostate, others.
• Dental.
• Epilepsy.
• Fibromyalgia.
• Migraine.
• Multiple sclerosis.
• Surgical.

A regional analysis of these product segments is also provided, including the specific countries listed below and including countries not listed as a rest of the world market.

• Argentina.
• Australia/New Zealand.
• Brazil.
• Canada.
• China.
• France.
• Germany.
• Italy.
• Japan.
• Mexico.
• Russia.
• Spain.
• United Kingdom.
• United States.

Each market segment provides detailed information based on product categories, product use, current market value and forecasts.

Not covered in the report are drugs or devices that are considered conventional in professional treatment guidelines that are due to either controversial issues such as those with medical cannabis or those that are not commonly prescribed or recommended due to a lack of clinical data, education or other factors.

Report Includes:

• 46 data tables and 19 additional tables
• An overview of the global market for non-opioid pain treatments
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
• Market breakdown by type, segment, indication, application, and country
• Identification of segments with high growth potential and their future applications
• Explanation of major drivers and regional dynamics of the market and current trends within the industry
• Detailed profiles of major vendors in the market, including Allergan Plc, Aphria Inc., Canopy Growth Corp., Cara Therapeutics and Cronos Group

Key Topics Covered:

1. Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related Reports

2. Summary and Highlights
Market Overview
Regional Market Summary
Drivers and Restraints

3. Market Overview and Background
History of Pain and Pain Treatment
Types of Pain
Physiological Pain Classifications
How Pain is Diagnosed
How Pain is Treated
Opioid vs. Non-opioid Pain Control
Alternative Methods of Pain Management
Alternative Non-opioid Therapies for Treating Pain
Medical Cannabis
Capsaicin-derived Compound
Menthol-containing Compound
Omega 3 Fatty Acid-containing Supplements
Botulinum Toxins (OnabotulinumtoxinA/RimabotulinumtoxinB)
Others
Growing Trend in Cannabis Treatment for Pain
Adoption of Medical Cannabis: A Global Analysis
Laws and Legalization Trends
Claims in Effectiveness
Potency and Validation Testing Trends
Access to Palliative Care Around the World
Assessing the Need for Palliative Care
Market Influences and Indicators of Growth

4. Market Breakdown by Product Segment
Overview
Medical Cannabis
Capsaicin-derived Therapies
Menthol-containing Therapies
Omega-3 Fatty Acid-containing Therapies
Botulinum Toxin Treatments

5. Market Breakdown by Therapeutic Application
Overview
Alternative Non-opioid Cancer Pain Treatment
Alternative Non-opioid Neuropathic Pain Treatment
Alternative Non-opioid Orthopedic/Musculoskeletal Pain Treatments
Other Alternative Non-opioid Pain Treatments

6. Market Breakdown by Region
Overview
Regional Groupings
North America
Canada
United States
EMEA
France
Germany
Italy
Russia
Spain
United Kingdom
Asia-Pacific
Australia/New Zealand
China
Japan
Latin America
Argentina
Brazil
Mexico

7. Patent Analysis
Patent Analysis Overview
Non-opioid Pain Relief Categories
Medical Cannabis
Technologies
Cannabis Patent Review by Year
Patent Review by Company
Patent Review by Major Country
Patent Review by Assignee

8. Company Profiles

• Allergan PLC
• Aphria Inc.
• Aurora
• Bedrocan
• Canopy Growth Corp.
• Cara Therapeutics
• Centrexion Therapeutics
• CHT Medical
• Cronos Group
• GW Pharmaceuticals
• Medical Marijuana Inc.
• Medropharm Gmbh
• Panag Pharma Inc.
• Tilray
• US Worldmeds LLC
• Vanway

For more information about this report visit https://www.researchandmarkets.com/research/plxwdl/global_nonopioid?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Analgesics, Addiction Disorders Drugs